Metropolitan Hospital is the only hospital in Greece equipped with the Visualase® system, a pioneering minimally invasive technology for treating neuro-oncological conditions and epilepsy, delivering outstanding results in selected cases.
Visualase® provides a therapeutic option for patients with brain tumors that are surgically inaccessible, as well as for those who do not respond to chemotherapy or radiotherapy.
Key features and advantages of the Visualase® system include: (ΜΕΣΟΤΙΤΛΟΣ ΜΕ BOLD)
- Precision and safety in targeting epileptogenic or pathological brain areas through laser ablation
- Real-time MRI imaging during the procedure for accurate monitoring
- Minimally invasive technique without the need for large incisions or craniotomy
- Minimal postoperative hospitalization — patients are typically discharged the next day
- Ideal for challenging or sensitive brain regions where traditional surgery carries increased risk
The use of Visualase® significantly enhances the treatment capabilities of Neurosurgery Department, establishing it as a leading center in Greece for innovative management of epilepsy and intracranial lesions